Skip to search formSkip to main contentSkip to account menu

Myocet

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Doxorubicinliposome-encapsulated doxorubicin citrate complex

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
FLAG-liposomal Doxorubicin (Myocet) Regimen for Refractory or Relapsed Acute Leukemia Pediatric Patients
Despite the success in treating the majority of children with newly diagnosed acute leukemia, children with relapsed or… 
2011
2011
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer.
2008
2008
Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenografts
Malignant glioma patients have a life expectancy reduced to about 15 months despite aggressive surgery, radiotherapy (RT), and… 
2008
2008
Liposomal-Encapsulated Doxorubicin (Myocet™; D-99) and Vinorelbine in Previously Treated Metastatic Breast Cancer Patients: A Feasibility Study
Aims and background We conducted a feasibility study to determine the safety and efficacy of liposome-encapsulated doxorubicin… 
2006
2006
Safety analysis of a phase II study of cyclophosphamide, vincristine, non-pegilated liposomal doxorubicin (Myocet), and prednisone + rituximab in biweekly regimen (R-COMP-14) as primary treatment of…
17532 Background: Gold standard treatment of CD20+ aggressive B-cell non-Hodgkin lymphoma, R-CHOP, has been suggested to improve… 
Highly Cited
2004
Highly Cited
2004
Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of…
PURPOSE To evaluate the safety and efficacy of liposomal doxorubicin (Myocet; Medeus Pharma Ltd, Herts,UK) when substituted for… 
2004
2004
Results of a phase II study of liposomal doxorubicin (Myocet®) in combination with weekly paclitaxel and trastuzumab (Herceptin®) In patients with HER2-positive locally advanced or metastatic breast…
2001
2001
Anthracyclines in breast cancer: therapy and issues of toxicity
2001
2001
Liposomal anthracyclines for improved cardiac tolerability
2001
2001
Liposomal doxorubicin (Myocet™) and conventional anthracyclines: a comparison
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)